<sub id="d1nvr"><font id="d1nvr"><dfn id="d1nvr"></dfn></font></sub>

    <address id="d1nvr"></address>

    <b id="d1nvr"><cite id="d1nvr"><ruby id="d1nvr"></ruby></cite></b><video id="d1nvr"></video>

    <form id="d1nvr"><var id="d1nvr"><address id="d1nvr"></address></var></form>

    <meter id="d1nvr"></meter>

    <form id="d1nvr"></form>

      Information is solely for medical professionals
      Beifuji Spray
      Recombinant Bovine Basic Fibroblast Growth Factor Spray
      /
      Specification 63000IU/15ml/bottle
      Beifuji  is a national  category I new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co.,Ltd..

      The API of Beifuji Spray is recombinant bovine basic fibroblast growth factor (rb-bFGF) – a multifunctional growth factor with a wide range of bioactivities, which can stimulate the proliferation and differentiation of cells in the process of wound healing and further improve the healing quality.
      Mechanism
      The API of Beifuji  is recombinant bovine basic fibroblast growth factor (rb-bFGF), which can stimulate the repair and regeneration of tissues and cells derived from the mesoderm and ectoderm (such as epithelial cells, dermal cells, fibroblasts, vascular endothelial cells, osteoblasts, nerve cells etc.). The specific combination of rb-bFGF with the wounded target cell surface can trigger the cells to repair actively and stimulate cell division, proliferation, migration and differentiation, so as to accelerate wound healing and improve the healing quality.
      Features
      · A state category I new drug based on the genetic engineering technology
      · Accelerate wound healing shortening the healing time and reducing scar formation
      · Safe and effective treatment without any side effect
      · Sterile formulation packaged aseptically, convenient for use
      Clinical Application
      · Burn and scald wounds: including shallow II degree and deep II degree wounds,granulation wounds and inhalation injuries
      · Acute wounds: bruises, contusions, combined injuries and cuts
      · Surgical incisions: incisions of surgery, orthopedics, gynaecology (such as lateral episiotomy and cesarean incision), otolaryngology, urology and proctology
      · Chronic wounds: diabetic ulcers, vascular ulcers, radiochemotherapy ulcers, bedsores, fistulas, residual wounds and cervical erosions
      · Skin grafting: skin donor site, skin grafting site, skin flap handling
      · Other applications: after plastic surgery, skin resurfacing, dermabrasion, nevus removal and laser therapy wounds
      Medical Guidelines
      · Chinese Dermatologist Consensus about Application of Recombinant Bovine Basic Fibroblast Growth Factor (rb-bFGF) for Laser and IPLS Treatment and Skin Barrier Repairment(2019)
      · Clinical Guidelines for Use of Exogenous Growth Factors in Skin Wounds, Chin J Burns(2017)
      · Expert Advice on Diagnosis and Treatment of Pemphigus Vulgaris (2016)
      · Chinese Guidelines for Diagnosis and Treatment of Skin Wounds (2015)
      This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.
      免费看男生裸体自慰_韩国公和熄2_黑帽门7分40视频_男同志FREEVOIDEOS免费